Steglatro (ertugliflozin)

pCPA File Number: 21098
Negotiation Status:
Concluded without agreement
Indication(s):
Diabetes Mellitus, Type 2
Sponsor/Manufacturer:
Merck Canada Inc.
CDA-AMC Project Number:
SR0565-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: